Technology Overload: Addressing Site Challenges of Digital Trials

Event Overview

While the digital transformation of clinical trials has made tremendous strides in recent years, the plethora of new technologies is overwhelming sites. To run one clinical trial, the investigative site team can use up to 15 different systems (e.g. EDC, EHR/EMR, payments, CTMS, radiology, technology vendors, etc.) on top of learning how to leverage remote site staff and virtual facilities. While technology should, in theory, make sites’ operations easier, the surplus of distinct point solutions can create burdens.

In this webcast, featured speakers will dive into the site experience and discuss the importance of implementing a change management strategy coupled with a unified digital trial platform that streamlines eConsent, eCOA, sensors and integration workflows into a single end-to-end experience. This will ensure productive sites that can focus on participants.

Key Learning Objectives

Site pain points associated with digital trials (lack of flexibility, autonomy, and budget)
Guidelines to ensure the optimal combination of technologies for sites
Effective change management tactics to make sites comfortable with new technologies
A case study of effective digital trial implementation to maximize site productivity
Sponsor of Choice: Empowering Sites with a Voice

Who Should Attend

Large Pharma, Biotechs, & CROs
Clinical IT, Business IT, Clinical Operations/Research/Development, Study Management, Therapeutic Area Leads, Portfolio Leads, Innovation Leads, Procurement Leads, Science Teams, Medical Affairs, Data Management/Analysis/Process, Regulatory Affairs Heads, QA/QC, R&D, Chief Medical/Scientific Officers, Patient-centric Titles

Featured Speakers

Andrew Mackinnon

VP & General Manager, eConsent

Medable

As General Manager for eConsent, Andrew oversees the development of the eConsent product, as well as the implementation of eConsent in Medable studies, ensuring that Medable’s clients can run high quality, effective and efficient decentralized clinical trials. Andrew has 20 years of experience in managing clinical trials at large Pharma, Biotech and CRO companies, most recently as a Senior Director in one of Covance’s therapeutic area delivery groups and as Head of Business Performance. From his involvement in one of the earliest deployments of decentralized methodologies, he has been passionate about the benefits that this approach can bring in reducing the burden of clinical research on both sites and patients and looks to leverage his broad operational expertise to improve how this approach is utilized.

Katie Madden

Director of Digital Health Process Optimisation

GSK

As a Project Management Professional (PMP) and a Senior Manager within Digital, Analytics, and Performance, Katie is focused on the delivery of Digital Health technology within Clinical Operations. With over 10 years in the industry, Katie has front-line experience in trial delivery, intimate-knowledge of various trial supporting technology, and decentralized trials. Katie is currently, committed to ensuring that the process for asset teams to deploy novel and innovative, digital designs and features, is a paved road with a focus on agility, compliance, ethics, and safety. Katie is a published author as well as a Strategic Owner for an initiative that was a 2022 Reuters award winner for Most Valuable Digital Patient Engagement.

Annie Hesslewood

Patient & Site, Global Adoption Lead

Medbale

Annie has worked in the clinical research industry for over 20 years. Starting out as a nurse/site coordinator in South Africa and moving into the clinical research industry as a site monitor for Bayer before moving to the UK. Over the years Annie has worked in various roles in the clinical research industry covering all phases of clinical research specializing in a wide range of therapeutic areas. Annie has provided her expertise at both pharma companies and various CROs, most recently at Covance where she successfully led and built the Clinical Team Leads focused on client delivery and excellence in quality. At Medable, Annie has spearheaded the development of a global Site Adoption Team aimed at supporting clients, sites and internal teams in order to ensure the seamless adoption of technology.

Nathan Morton

Consultant

Alcanza Clinical Research

Nathan has over 18 years of site experience, including the execution of over 600 industry clinical trials. Nathan has served in a variety of roles involving strategic planning, volunteer recruitment, contracts/budgets, investigator outreach, study start-up oversight, regulatory compliance, and clinical operational management. Nathan earned a bachelor’s degree at the University of Tennessee, Knoxville, and served for 4 years as a Korean linguist in the United States Navy. Within the clinical research arena, he has served as a member of several industry groups including the IQVIA Diversity Site Alliance, the Moderna Site Advisory Group Experience, and the Medable DCT Site Network Council.

For any technical questions please contact Kristina Dunphey: kdunphey@mjh events.com

Complete this form to enter the webcast. (* indicates required field)

Technology Overload: Addressing Site Challenges of Digital Trials

Wed, Aug 30, 2023 11:00 AM EDT{LOCAL_TZ}

Complete this form to enter the webcast.
(* indicates required field)